Dr Reddy's Issues Recall for Six Drug Lots in US Over Subpotency Concerns

Dr. Reddy's Laboratories, a prominent pharmaceutical company based in Hyderabad, has initiated a voluntary recall of six lots of a medication designed to lower blood phenylalanine (Phe) levels in the United States. This action comes after the discovery of subpotency issues linked to powder discoloration in some packets of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg. The company disclosed this information through a regulatory filing, highlighting the commitment to ensuring the safety and efficacy of its products.

Representative image

The subpotency issue was identified during accelerated stability testing and was further supported by customer complaints. Dr. Reddy's Laboratories has expressed concerns that the reduced efficacy of the product could lead to increased Phe levels in patients. Elevated Phe levels, especially if persistent over time in infants and children, can result in severe neurocognitive consequences. These include irreversible intellectual disability, developmental delays, and seizures, underscoring the critical nature of this recall.

To date, Dr. Reddy's Laboratories Inc., the US-based arm of the company, has not received any reports of adverse events related to this recall. The company is proactively reaching out to its distributors and customers with recall notification letters and is arranging for the return of all recalled products. This measure is part of Dr. Reddy's Laboratories' broader effort to mitigate any potential health risks associated with the affected lots.

Dr. Reddy's Laboratories is urging anyone with an existing inventory of the recalled Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to inspect their stock and immediately quarantine any of the affected lots. Furthermore, consumers who have purchased the product from the implicated lots are advised to return it to their place of purchase. This recall reflects Dr. Reddy's Laboratories' dedication to maintaining high standards of product quality and patient safety.